O
ACH

OppenheimerFunds’s Accendra Health ACH Stock Holding History

OppenheimerFunds’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$4.86M Buy
1,186,219
+436,116
+58% +$2.76M 0.01% 751
2018
Q4 		$4.75M Buy
750,103
+364,931
+95% +$3.79M 0.01% 746
2018
Q3 		$6.36M Buy
385,172
+27,135
+8% +$461K 0.01% 760
2018
Q2 		$5.98M Buy
358,037
+8,292
+2% +$134K 0.01% 767
2018
Q1 		$5.44M Sell
349,745
-504,685
-59% -$9M 0.01% 756
2017
Q4 		$16.1M Buy
854,430
+766,444
+871% +$17M 0.02% 648
2017
Q3 		$2.57M Buy
87,986
+7,209
+9% +$213K ﹤0.01% 885
2017
Q2 		$2.6M Buy
80,777
+10,457
+15% +$343K ﹤0.01% 875
2017
Q1 		$2.43M Buy
70,320
+11,544
+20% +$412K ﹤0.01% 909
2016
Q4 		$2.07M Buy
58,776
+12,419
+27% +$420K ﹤0.01% 918
2016
Q3 		$1.61M Buy
46,357
+6,603
+17% +$231K ﹤0.01% 908
2016
Q2 		$1.49M Buy
39,754
+1,295
+3% +$48.7K ﹤0.01% 913
2016
Q1 		$1.55M Sell
38,459
-7,310
-16% -$272K ﹤0.01% 915
2015
Q4 		$1.65M Buy
+45,769
New +$1.66M ﹤0.01% 932

Other funds holding ACH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

OppenheimerFunds's ACH Position: Q1 2019 in Review

OppenheimerFunds increased its Accendra Health (ACH) stake by 58% in Q1 2019, buying an estimated $2.76M and bringing the position to 1,186,219 shares worth $4.86M. The position accounts for 0.01% of the portfolio, ranked #751.

OppenheimerFunds first reported a position in ACH in Q4 2015 and has held it in 14 quarters since. The position peaked at $16.1M in Q4 2017. 187 funds tracked by Wall St. Rank hold ACH as of Q1 2019.

  • OppenheimerFunds held 1,186,219 shares of Accendra Health worth $4.86M as of Q1 2019.
  • OppenheimerFunds bought 436,116 Accendra Health shares in Q1 2019, an estimated $2.76M.
  • Accendra Health made up 0.01% of OppenheimerFunds's portfolio in Q1 2019, its #751 holding.
  • OppenheimerFunds first reported a position in Accendra Health in Q4 2015 and has held it in 14 quarters since.
  • OppenheimerFunds's Accendra Health position peaked at $16.1M in Q4 2017.
  • 187 funds tracked by Wall St. Rank held Accendra Health as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.